Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001610618-18-000011
Filing Date
2018-02-27
Accepted
2018-02-27 16:43:22
Documents
77
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 CIDARA THERAPEUTICS, INC. 2017 FORM 10-K cdtx10-k2017x12x31.htm 10-K 1501262
2 LIST OF SUBSIDIARIES exhibit2112017-12x31.htm EX-21.1 3445
3 CONSENT OF INDEPENDENT PUBLIC ACCOUNTING FIRM exhibit2312017-12x31.htm EX-23.1 4611
4 CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit3112017-12x31.htm EX-31.1 13686
5 CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit3122017-12x31.htm EX-31.2 13798
6 CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit3212017-12x31.htm EX-32.1 7164
7 CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit3222017-12x31.htm EX-32.2 7039
14 performancegraph20171231a01.jpg GRAPHIC 46058
15 ph1pkgraph.jpg GRAPHIC 141887
  Complete submission text file 0001610618-18-000011.txt   6139271

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cdtx-20171231.xml EX-101.INS 980071
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdtx-20171231.xsd EX-101.SCH 42393
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdtx-20171231_cal.xml EX-101.CAL 65426
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdtx-20171231_def.xml EX-101.DEF 219818
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdtx-20171231_lab.xml EX-101.LAB 607229
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdtx-20171231_pre.xml EX-101.PRE 363244
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36912 | Film No.: 18645775
SIC: 2836 Biological Products, (No Diagnostic Substances)